Examiner: DAHLIN, HEATHER RAQUEL

Tech Center 1600 • Art Units: 1628 1629

This examiner grants 41% of resolved cases

Performance Statistics

41.4%

Allow Rate

-18.6% vs TC avg

223

Total Applications

+50.4%

Interview Lift

1215

Avg Prosecution Days

Based on 152 resolved cases, 2023–2026

4.4%

§101 Eligibility

19.5%

§102 Novelty

34.8%

§103 Obviousness

25.2%

§112 Clarity

App #	Title	Status	Assignee
18035152	Use of 5-HT3-Targeting Drugs for Treatment of Acute Kidney Injury	Final Rejection	University of Pittsburgh-Of the Commonwealth System of Higher Education
18122465	PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVE AND USE THEREOF	Non-Final OA	Tencent Technology (Shenzhen) Company Limited
18273322	PROCESSES FOR PREPARING PYRROLOPYRIDINE-ANILINE COMPOUNDS	Non-Final OA	NFLECTION THERAPEUTICS, INC.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.